evt | News | June 25, 2020
MERLION Study Evaluates Early Outcomes of iVascular's Luminor DCB to Treat TASC C and D Tibial Disease
June 25, 2020—Professor Tjun Tang, MD, presented interim 6-month results from the MERLION study exploring the iVascular Luminor drug-coated balloon (DCB) in infrapopliteal atherosclerotic lesions in chronic limb threatening ischemia (CLTI) patients with a high incidence of diabetes mellitus (DM) and end-stage renal failure (ESRF).
evt | News | October 12, 2020
Enrollment Begins for MedAlliance’s PRISTINE Registry of the Selution SLR Sirolimus-Eluting Balloon
October 12, 2020—MedAlliance announced that the first two patients have been enrolled in the PRISTINE registry, which is evaluating the company’s Selution SLR (sustained limus release) sirolimus drug-eluting balloon for the treatment of patients with chronic limb-threatening ischemia (CLTI).
evt | News | January 10, 2020
Enrollment Completed in PRESTIGE BTK Trial of MedAlliance’s Selution SLR Device
January 10, 2020—MedAlliance announced the completion of patient enrollment in the PRESTIGE below-the-knee clinical trial, which is evaluating the 6-month safety and performance outcomes of the company’s Selution SLR sirolimus-eluting balloon catheter for the treatment of long tibial occlusive lesions (TASC C & D) in patients with critical limb ischemia.
evt | News | August 28, 2019
FDA Grants Breakthrough Device Designation for Concept Medical's MagicTouch AVF Sirolimus-Coated Balloon
August 29, 2019—Concept Medical Inc. announced that it has been granted FDA Breakthrough Device designation for the company's MagicTouch arteriovenous fistula (AVF) sirolimus-coated balloon (SCB) catheter for the treatment of stenotic lesions of AVFs or AV grafts (AVGs) in hemodialysis treatment of renal failure.
evt | News | November 20, 2017
Neuroform, Enterprise, and LVIS Self-Expanding Stents Compared for Treating Cerebral Aneurysms
November 21, 2017—A study by Jun Wang, MD, et al compared the clinical and angiographic outcomes of treating cerebral aneurysms with three self-expanding nitinol stents: Neuroform (Stryker), Enterprise (Codman Neuro), and Low-profile Visualized Intraluminal Support stents (LVIS/LVIS Jr; MicroVention Terumo).
evt | Article | October 2018
Metastatic Osseous Disease: Current Interventional Oncology Treatment Options
Minimally invasive therapies such as embolization, thermal ablation, and consolidative therapy can be used for locoregional control and pain palliation or can be combined for a synergistic effect.
By Steven Yevich, MD, MPH